Medexus Pharmaceuticals Inc. (MDP.TO)
CAD 2.04
(-5.99%)
CAD 2.04
(-5.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 30.77 Million USD | 34.68% |
| 2022 | 22.84 Million USD | 7.01% |
| 2021 | 21.35 Million USD | 45.57% |
| 2020 | 14.66 Million USD | 4.11% |
| 2019 | 14.08 Million CAD | 232.44% |
| 2018 | 4.23 Million CAD | 149.98% |
| 2017 | 1.69 Million CAD | 32.63% |
| 2016 | 1.27 Million CAD | 172.23% |
| 2015 | 469.52 Thousand CAD | 60.99% |
| 2014 | 291.64 Thousand CAD | -16.23% |
| 2013 | 348.14 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 36.26 Million USD | 17.83% |
| 2023 Q4 | 30.77 Million USD | 12.06% |
| 2023 Q1 | 25 Million USD | 9.43% |
| 2023 Q2 | 24.85 Million USD | -0.61% |
| 2023 Q3 | 27.46 Million USD | 10.5% |
| 2023 FY | 30.77 Million USD | 34.68% |
| 2022 Q1 | 21.97 Million USD | 2.94% |
| 2022 Q4 | 22.84 Million USD | 1.98% |
| 2022 Q3 | 22.4 Million USD | -5.7% |
| 2022 FY | 22.84 Million USD | 7.01% |
| 2022 Q2 | 23.75 Million USD | 8.09% |
| 2021 Q2 | 14.4 Million USD | 10.14% |
| 2021 Q4 | 21.35 Million USD | 31.99% |
| 2021 Q3 | 16.17 Million USD | 12.27% |
| 2021 Q1 | 13.08 Million USD | -10.81% |
| 2021 FY | 21.35 Million USD | 45.57% |
| 2020 Q2 | 14.23 Million CAD | -1.54% |
| 2020 FY | 14.66 Million USD | 4.11% |
| 2020 Q3 | 13.12 Million CAD | -7.83% |
| 2020 Q4 | 14.66 Million USD | 11.75% |
| 2020 Q1 | 14.46 Million CAD | 2.66% |
| 2019 Q4 | 14.08 Million CAD | 136.57% |
| 2019 FY | 14.08 Million CAD | 232.44% |
| 2019 Q3 | 5.95 Million CAD | 43.13% |
| 2019 Q1 | 3.93 Million CAD | -7.14% |
| 2019 Q2 | 4.16 Million CAD | 5.73% |
| 2018 Q1 | 1.38 Million CAD | -18.46% |
| 2018 Q4 | 4.23 Million CAD | 21.67% |
| 2018 FY | 4.23 Million CAD | 149.98% |
| 2018 Q2 | 1.48 Million CAD | 7.77% |
| 2018 Q3 | 3.48 Million CAD | 133.81% |
| 2017 FY | 1.69 Million CAD | 32.63% |
| 2017 Q1 | 1.63 Million CAD | 27.54% |
| 2017 Q4 | 1.69 Million CAD | 13.53% |
| 2017 Q3 | 1.49 Million CAD | -25.73% |
| 2017 Q2 | 2.01 Million CAD | 23.34% |
| 2016 Q3 | 1.18 Million CAD | 39.04% |
| 2016 FY | 1.27 Million CAD | 172.23% |
| 2016 Q2 | 850.96 Thousand CAD | 30.41% |
| 2016 Q4 | 1.27 Million CAD | 8.03% |
| 2016 Q1 | 652.52 Thousand CAD | 38.98% |
| 2015 Q2 | 357.66 Thousand CAD | 18.34% |
| 2015 Q1 | 302.22 Thousand CAD | 3.63% |
| 2015 FY | 469.52 Thousand CAD | 60.99% |
| 2015 Q4 | 469.52 Thousand CAD | 1.72% |
| 2015 Q3 | 461.58 Thousand CAD | 29.05% |
| 2014 Q3 | 338.79 Thousand CAD | 6.94% |
| 2014 Q2 | 316.79 Thousand CAD | 29.97% |
| 2014 FY | 291.64 Thousand CAD | -16.23% |
| 2014 Q1 | 243.73 Thousand CAD | 0.0% |
| 2014 Q4 | 291.64 Thousand CAD | -13.92% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | 382.46 Thousand CAD | 0.0% |
| 2013 FY | 348.14 Thousand CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | -100.0% |
| 2012 Q3 | 106.83 Thousand CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 83.489% |
| Avicanna Inc. | 4.54 Million CAD | -577.165% |
| Avant Brands Inc. | 28.93 Million CAD | -6.341% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 11095.026% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | -402.4% |
| Knight Therapeutics Inc. | 91.83 Million CAD | 66.492% |
| MediPharm Labs Corp. | 9.89 Million CAD | -210.86% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | 61.988% |
| Canopy Growth Corporation | 77.29 Million CAD | 60.187% |
| Willow Biosciences Inc. | 221 Thousand CAD | -13823.982% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | 2.09% |